Altered global histone-trimethylation code and H3F3A-ATRX mutation in pediatric GBM

Journal of Neuro-Oncology

Volumn 121, Issue 3, 2015, Pages 489-497

  Pathak, Pankaj ^a   Jha, Prerana ^a   Purkait, Suvendu ^a   Sharma, Vikas ^a   Suri, Vaishali ^a   Sharma, Mehar C ^a   Faruq, Mohammed ^b   Suri, Ashish ^a   Sarkar, Chitra ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

ATRX; EZH2; H3F3A; H3K4me3 H3K27me3; H3K9me3; Pediatric glioblastoma

Indexed keywords

TRANSCRIPTION FACTOR EZH2; ATRX PROTEIN, HUMAN; DNA HELICASE; HISTONE; NUCLEAR PROTEIN;

ARTICLE; ATRX GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DAXX GENE; FEMALE; GENE EXPRESSION REGULATION; GLIOBLASTOMA; H3F3A GENE; H3K27 GENE; H3K36 GENE; H3K4 GENE; H3K9 GENE; HIST1H3B GENE; HISTONE CODE; HISTONE METHYLATION; HUMAN; HUMAN TISSUE; IDH1 GENE; IMMUNOHISTOCHEMISTRY; MALE; MUTATIONAL ANALYSIS; PEDIATRICS; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TUMOR GENE; TUMOR SUPPRESSOR GENE; CHILD; DNA METHYLATION; GENETICS; NUCLEOTIDE SEQUENCE; RETROSPECTIVE STUDY;

CHILD; DNA HELICASES; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; GLIOBLASTOMA; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR PROTEINS; RETROSPECTIVE STUDIES;

EID: 84925490788     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1675-z     Document Type: Article

References (39)

1. Broniscer A, Gajjar A (2004) Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 9:197–206
2. Tamber MS, Rutka JT (2003) Pediatric supratentorial high-grade gliomas. Neurosurg Focus 14:e1 Review
3. Suri V, Das P, Pathak P, Jain A, Sharma MC et al (2009) Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro Oncol 11:274–280
4. Gilheeney SW, Kieran MW (2012) Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters. Future Oncol 8:549–558
5. Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E et al (2012) Driver mutations in histone H3.3 and chromatin remodeling genes in pediatric glioblastoma. Nature 482:226–231
6. Appin CL, Brat DJ (2014) Molecular genetics of gliomas. Cancer J 20(1):66–72
7. Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and nonbrainstem glioblastomas. Nat Genet 44:251–253
8. Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM et al (2014) Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathol 127:881–895
9. Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD (2010) Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci USA 107:14075–14080
10. Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425–437
11. Bender S, Tang Y, Lindroth AM, Hovestadt V, Jones DT et al (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24:660–672
12. Martin C, Zhang Y (2005) The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 6:838–849
13. klose RJ, Zhang Y (2007) Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 8:307–318
14. Margueron R, Reinberg D (2011) The Polycomb complex PRC2 and its mark in life. Nature 469:343–349
15. Liu L, Xu Z, Zhong L, Wang H, Jiang S et al (2013) Prognostic value of EZH2 expression and activity in renal cell carcinoma: a prospective study. PLoS ONE 8:e81484
16. Holm K, Grabau D, Lövgren K, Aradottir S, Gruvberger-Saal S et al (2012) Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Mol Oncol 6:494–506
17. Shen L, Cui J, Liang S, Pang Y, Liu P (2013) Update of research on the role of EZH2 in cancer progression. Onco Targets Ther 6:321–324
18. Orzan F, Pellegatta S, Poliani PL, Pisati F, Caldera V et al (2011) Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Neuropathol Appl Neurobiol 37:381–394
19. Venneti S, Garimella MT, Sullivan LM, Martinez D, Huse JT et al (2013) Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas. Brain Pathol 23:558–564
20. Chan KM, Fang D, Gan H, Hashizume R, Yu C et al (2013) The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev 27:985–990
21. Lewis PW, Müller MM, Koletsky MS, Cordero F, Lin S et al (2013) Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340:857–861
22. Zhang A, Xu B, Sun Y, Lu X, Gu R et al (2012) Dynamic changes of histone H3 trimethylated at positions K4 and K27 in human oocytes and preimplantation embryos. Fertil Steril 98:1009–1016
23. Nakazawa T, Kondo T, Ma D, Niu D, Mochizuki K et al (2012) Global histone modification of histone H3 in colorectal cancer and its precursor lesions. Hum Pathol 43:834–842
24. Rogenhofer S, Kahl P, Mertens C, Hauser S, Hartmann W et al (2012) Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma. BJU Int 109:459–465
25. Dubuc AM, Remke M, Korshunov A, Northcott PA, Zhan SH et al (2013) Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathol 125:373–384
26. Watanabe T, Morinaga S, Akaike M, Numata M, Tamagawa H et al (2012) The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pancreatic cancer patients treated with surgery. Eur J Surg Oncol 38:1051–1057
27. Tamagawa H, Oshima T, Numata M, Yamamoto N, Shiozawa M et al (2013) Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer. Eur J Surg Oncol 39:655–661
28. Chen YW, Kao SY, Wang HJ, Yang MH (2013) Histone modification patterns correlate with patient outcome in oral squamous cell carcinoma. Cancer 119:4259–4267
29. Chapman-Rothe N, Curry E, Zeller C, Liber D, Stronach E et al (2013) Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells. Oncogene 32:4586–4592
30. Rogenhofer S, Miersch H, Göke F, Kahl P, Wieland WF et al (2013) Histone methylation defines an epigenetic entity in penile squamous cell carcinoma. J Urol 189:1117–1122
31. Jha P, Suri V, Sharma V, Singh G, Sharma MC et al (2011) IDH1 mutations in gliomas: first series from a tertiary care centre in India with comprehensive review of literature. Exp Mol Pathol 91:385–393
32. Zhang Y, Reinberg D (2001) Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15:2343–2360
33. Greer EL, Shi Y (2012) Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 13:343–357
34. Venneti S, Felicella MM, Coyne T, Phillips JJ, Gorovets D et al (2013) Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas. J Neuropathol Exp Neurol 72:298–306
35. Fontebasso AM, Schwartzentruberentruber J, Khuong-Quang DA, Liu XY, Sturm D et al (2013) Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas. Acta Neuropathol 125:659–669
36. Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124:439–447
37. Fontebasso AM, Liu XY, Sturm D, Jabado N (2013) Chromatin remodeling defects in pediatric and young adult glioblastoma: a tale of a variant histone 3 tail. Brain Pathol 23:210–216
38. Venneti S, Santi M, Felicella MM, Yarilin D, Phillips JJ et al (2014) A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Acta Neuropathol 128(5):743–753
39. Buczkowicz P, Bartels U, Bouffet E, Becher O, Hawkins C (2014) Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathol. doi:10.1007/s00401-014-1319-6